公开(公告)号：WO2006034234A1

公开(公告)日：2006-03-30

申请号：PCT/US2005/033560

申请日：2005-09-19

Applicant: ABBOTT LABORATORIES ,  ZHANG, Geoff, G. ,  GOLDSTEIN, Mark ,  WARDROP, Jaqueline

Inventor： ZHANG, Geoff, G. ,  GOLDSTEIN, Mark ,  WARDROP, Jaqueline

IPC: C07D405/10 ,  A61K31/4025 ,  A61P35/00

CPC classification number: C07D405/04 ,  C07B2200/13 ,  C07D405/10

Abstract: Atrasentan Hydrochloride Crystalline Form 3, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed

Abstract translation: 盐酸阿特拉森结晶形式3，含有它的组合物和治疗疾病的方法以及使用其抑制不良生理事件

公开(公告)号：WO2006034084A1

公开(公告)日：2006-03-30

申请号：PCT/US2005/033265

申请日：2005-09-19

Applicant: ABBOTT LABORATORIES ,  DZIKI, Walter ,  LU, Ziqi ,  RASMUSSEN, Michael, W. ,  WARDROP, Jaqueline ,  ZHANG, Geoff, G. ,  GOLDSTEIN, Mark ,  LINTON, Cathie, L.

Inventor： DZIKI, Walter ,  LU, Ziqi ,  RASMUSSEN, Michael, W. ,  WARDROP, Jaqueline ,  ZHANG, Geoff, G. ,  GOLDSTEIN, Mark ,  LINTON, Cathie, L.

IPC: C07D405/10 ,  A61K31/4025 ,  A61P35/00

CPC classification number: C07D405/10 ,  C07D405/04

Abstract: Atrasentan Hydrochloride Crystalline Form 2, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.

Abstract translation: 盐酸阿特拉森结晶形式2，含有它的组合物和治疗疾病的方法以及使用其抑制不良生理事件。

公开(公告)号：WO2006034085A1

公开(公告)日：2006-03-30

申请号：PCT/US2005/033266

申请日：2005-09-19

Applicant: ABBOTT LABORATORIES ,  ZHANG, Geoff, G. ,  GOLDSTEIN, Mark ,  WARDROP, Jaqueline

Inventor： ZHANG, Geoff, G. ,  GOLDSTEIN, Mark ,  WARDROP, Jaqueline

IPC: C07D405/10 ,  A61K31/4025 ,  A61P35/00

CPC classification number: C07D405/04 ,  C07D405/10

Abstract: Substantially amorphous atrasentan hydrochloride, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.

Abstract translation: 公开了基本上无定形的盐酸阿斯曲坦，含有它的组合物和治疗疾病的方法以及使用它的抑制不良生理事件。

公开(公告)号：WO2006034094A1

公开(公告)日：2006-03-30

申请号：PCT/US2005/033278

申请日：2005-09-19

Applicant: ABBOTT LABORATORIES ,  DZIKI, Walter ,  LU, Ziqi ,  RASMUSSEN, Michael, W. ,  WARDROP, Jaqueline ,  ZHANG, Geoff, G. ,  GOLDSTEIN, Mark

Inventor： DZIKI, Walter ,  LU, Ziqi ,  RASMUSSEN, Michael, W. ,  WARDROP, Jaqueline ,  ZHANG, Geoff, G. ,  GOLDSTEIN, Mark

IPC: C07D405/10 ,  A61K31/4025 ,  A61P35/00

CPC classification number: A61K31/4025 ,  C07D405/10

Abstract: Atrasentan Hydrochloride Crystalline Form 1, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.

Abstract translation: 盐酸阿特拉森结晶形式1，含有它的组合物和治疗疾病的方法以及使用其抑制不良生理事件。

公开(公告)号：EP1802610A1

公开(公告)日：2007-07-04

申请号：EP05796557.6

申请日：2005-09-19

Applicant: ABBOTT LABORATORIES

Inventor： DZIKI, Walter ,  LU, Ziqi ,  RASMUSSEN, Michael, W. ,  WARDROP, Jaqueline ,  ZHANG, Geoff, G. ,  GOLDSTEIN, Mark ,  LINTON, Cathie, L.

IPC: C07D405/10 ,  A61K31/4025 ,  A61P35/00

CPC classification number: C07D405/10 ,  C07D405/04

Abstract: Atrasentan Hydrochloride Crystalline Form 2, compositions containing it and methods of treatment of diseases and inhibition of adverse physiological events using it are disclosed.

Abstract translation: 公开了盐酸阿拉生坦晶型2，含有它的组合物以及使用它治疗疾病和抑制不利生理事件的方法。